3M Red Dot Monitoring Electrode with Foam Tape - Product Usage: intended to be used by healthcare...

FDA Device Recall #Z-0423-2021 — Class II — September 15, 2020

Recall Summary

Recall Number Z-0423-2021
Classification Class II — Moderate risk
Date Initiated September 15, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm 3M Company - Health Care Business
Location Saint Paul, MN
Product Type Devices
Quantity 720,000

Product Description

3M Red Dot Monitoring Electrode with Foam Tape - Product Usage: intended to be used by healthcare professionals for ECG monitoring. 50 electrodes per pouch; 20 pouches per shipper box (1000 electrodes total).

Reason for Recall

Corrosion could cause performance failures in the product.

Distribution Pattern

Worldwide distribution - US Nationwide distribution and the countries of Europe (Austria, Belgium, Switzerland, Germany, Spain, Finland, France, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Sweden) and Worldwide (China, Taiwan, Singapore, Indonesia, Japan, Mexico, Peru, Costa Rica, Canada).

Lot / Code Information

Cat. No. 2228 (SKU: 70-2011-8514-0, SAP # 7100212952). GTIN: 10707387789524 (pouch) and 50707387789522 (shipper) Lots: 202204MA (Expiration 2020-04-27)

Other Recalls from 3M Company - Health Care Business

Recall # Classification Product Date
Z-0743-2025 Class II Clarity Precision Grip Attachments, for use in ... Nov 22, 2024
Z-0038-2025 Class II 3M Tegaderm CHG, Chlorhexidine Gluconate I.V. S... Aug 14, 2024
Z-1633-2024 Class II 3M Durapore Surgical Tape, Catalog Number 1538-118 Mar 20, 2024
Z-1475-2024 Class II 3M Tube Securement Device, Small, 1.7 IN/PO x 2... Feb 20, 2024
Z-1170-2024 Class II 3M Specialty Blade Assembly, REF 9660,70-2011-8... Jan 12, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.